BioPharma Resources

Drugs by condition

Drugs approved for anemia

Brand-name prescription drugs and biologics whose FDA label lists anemia as an approved use. Matched on the label phrases: "anemia".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

47

Still marketed, NDA or BLA

Drug classes

13

Novel drugs

22

New molecular entities and new biologics

In development

25

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for anemia.

  • Vykoura (Leucovorin Calcium) · Avyxa Holdings Feb 3, 2026
  • Imaavy (Nipocalimab-Aahu) · Janssen Biotech NovelPriority reviewOrphanApr 29, 2025
  • Rytelo (Imetelstat Sodium) · Geron NovelOrphanJun 6, 2024
  • Xromi (Hydroxyurea) · Nova Labs LTD Priority reviewOrphanApr 4, 2024
  • Vafseo (Vadadustat) · Akebia NovelMar 27, 2024

All approved drugs for anemia, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 256 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Nucleoside Metabolic Inhibitor (4)

  • Inqovi Cedazuridine, Decitabine · Taiho Oncology · 2020
  • Vidaza Azacitidine · Bristol-Myers · 2004
  • Nipent Pentostatin · Hospira INC · 1991
  • Azacitidine Azacitidine · Actavis LLC · 2016

Iron Chelator (3)

Parenteral Iron Replacement (3)

  • Ferrlecit Sodium Ferric Gluconate Complex · Sanofi Aventis US · 1999
  • Feraheme Ferumoxytol · Azurity · 2009
  • Venofer Iron Sucrose · Am Regent · 2000

Antimetabolite (3)

  • Droxia Hydroxyurea · Waylis Therap · 1967
  • Xromi Hydroxyurea · Nova Labs LTD · 2024
  • Siklos Hydroxyurea · Theravia · 2017

Corticosteroid (3)

  • Medrol Methylprednisolone · Pfizer · 1957
  • Kenalog-40 Triamcinolone Acetonide · Apothecon · 1965
  • Cortef Hydrocortisone · Pharmacia and Upjohn · 1952

Antifibrinolytic Agent (2)

  • Amicar Aminocaproic Acid · Hikma · 1964
  • Amicar Aminocaproic Acid · Hikma · 1964

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (1)

  • Vafseo Vadadustat · Akebia · 2024

Pyruvate Kinase Activator (1)

  • Pyrukynd Mitapivat Sulfate · Agios Pharms INC · 2022

Erythroid Maturation Agent (1)

  • Reblozyl Luspatercept-Aamt · Celgene Corp · 2019

Thalidomide Analog (1)

  • Revlimid Lenalidomide · Bristol Myers Squibb · 2005

Erythropoiesis-stimulating Agent (1)

  • Aranesp Darbepoetin Alfa · Amgen · 2001

Anti-epileptic Agent (1)

  • Felbatol Felbamate · Mylan Speciality Lp · 1993

Class not listed in FDA's data (23)

  • Imaavy Nipocalimab-Aahu · Janssen Biotech · 2025
  • Rytelo Imetelstat Sodium · Geron · 2024
  • Ojjaara Momelotinib Dihydrochloride · Glaxosmithkline · 2023
  • Promacta Eltrombopag Olamine · Novartis · 2008
  • Mircera Methoxy Polyethylene Glycol-Epoetin Beta · Hoffman-La Roche · 2007
  • Epogen/Procrit Epoetin Alfa · Amgen · 1989
  • Desferal Deferoxamine Mesylate · Mitem Pharma · 1968
  • Celestone Soluspan Betamethasone Acetate, Betamethasone Sodium Phosphate · Organon · 1965
  • Vykoura Leucovorin Calcium · Avyxa Holdings · 2026
  • Alvaiz Eltrombopag Choline · Teva Pharms INC · 2023
  • Monoferric Ferric Derisomaltose · Pharmacosmos · 2020
  • Khapzory Levoleucovorin · Acrotech Biopharma · 2018
  • Retacrit Epoetin Alfa-Epbx · Hospira INC · 2018
  • Promacta Kit Eltrombopag Olamine · Novartis · 2015
  • Auryxia Ferric Citrate · Keryx Biopharms · 2014
  • Injectafer Ferric Carboxymaltose · Am Regent · 2013
  • Orapred Odt Prednisolone Sodium Phosphate · Advanz Pharma · 2006
  • Lupron Depot Leuprolide Acetate · Abbvie Endocrine INC · 1997
  • Lupron Depot Leuprolide Acetate · Abbvie Endocrine INC · 1990
  • Pediapred Prednisolone Sodium Phosphate · Pai Holdings · 1986
  • Depo-Medrol Methylprednisolone Acetate · Pfizer · 1959
  • Solu-Medrol Methylprednisolone Sodium Succinate · Pharmacia and Upjohn · 1959
  • Solu-Cortef Hydrocortisone Sodium Succinate · Pharmacia and Upjohn · 1955

Drugs in development for anemia

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • CM336group, QiShen YiQi Dripping Pills 3 bagsPhase 37 trials

    Keymed Biosciences Co.Ltd · Multiple Myeloma (MM), Primary Light-Chain Amyloidosis, Primary Immune Thrombocytopenia

  • GR1803Velinotamig specified specified days., CLN-803Phase 37 trials

    Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Multiple Myeloma, Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)

  • PovetaciceptALPN-303Phase 37 trials

    Vertex Pharmaceuticals · Immunoglobulin A Nephropathy, Myasthenia Gravis, Generalized, Primary Membranous Nephropathy

  • AND017Phase 36 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, β -Thalassemia, Cancer-Related Anemia

  • CM313Phase 36 trials

    Keymed Biosciences Co.Ltd · Systemic Lupus Erythematosus, Primary Immune Thrombocytopenia, Platelet Transfusion Refractoriness

  • ElriterceptTAK-226, KER-050Phase 36 trials

    Takeda · Myelodysplastic Syndromes, Myelofibrosis, Anemia

  • ObexelimabPhase 34 trials

    Zenas BioPharma (USA), LLC · Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, Relapsing Multiple Sclerosis

  • ESAErythropoiesis-Stimulating AgentPhase 33 trials

    Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, Anemia of Chronic Kidney Disease

  • Zola-celBMS-986353, CC-97540Phase 33 trials

    Bristol Myers Squibb · Systemic Sclerosis, Lupus Erythematosus, Systemic, Lupus Nephritis

  • HMPL-523SovleplenibPhase 32 trials

    Hutchmed · Warm Antibody Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenia (ITP)

  • RoxadustatFG-4592, ASP1517Phase 32 trials

    Astellas · Chronic Kidney Disease, Renal Anemia, Myelodysplastic Syndromes

  • BCD-131pegdarbepoetin betaPhase 31 trial

    Biocad · Anemia, Chronic Kidney Disease, Chronic Kidney Disease Patients on Hemodialysis

  • RimiducidAP1903Phase 23 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • DibotatugDR-01Phase 22 trials

    Dren Bio · Bone Marrow Failure Syndromes, Aplastic Anemias, Severe Aplastic Anemia (SAA)

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • HBI-002Phase 22 trials

    Hillhurst Biopharmaceuticals, Inc. · Parkinson Disease, Anemia, Sickle Cell

  • OfirnoflastHT-6184Phase 22 trials

    Halia Therapeutics, Inc. · Myelodysplastic Syndromes, Anemia, Myelodysplastic Syndrome

  • rivogenlecleucelBPX-501 T cells, BPX-501Phase 22 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • SSS17Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Postoperative Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee

  • BMS-986470Phase 21 trial

    Bristol Myers Squibb · Anemia, Sickle Cell, Healthy Volunteers

3 discontinued brand-name drugs whose label still names it

More on anemia: recruiting trials · published research

Related in hematology and blood cancers: Multiple myeloma · Acute myeloid leukemia · Chronic lymphocytic leukemia · Acute lymphoblastic leukemia · Chronic myeloid leukemia · Lymphoma (non-Hodgkin) · Hodgkin lymphoma · Myelodysplastic syndromes · Myelofibrosis · Sickle cell disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.